Rachel King - Insider Trading & Ownership

Entity
Individual
Location
C/O Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg, MD
Summary
The estimated net worth of Rachel King is at least $2.2M dollars as of November 14, 2024. Rachel King is the Director of GLYCOMIMETICS INC and owns shares of GLYCOMIMETICS INC (GLYC) stock worth about $1.55M. Rachel King is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $656K.
All Insider Reports
All Insider Reports

Ownership of Rachel King

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLYC GLYCOMIMETICS INC Director $1.55M May 1, 2024
NVAX NOVAVAX INC Director $656K Jun 12, 2024
FULC Fulcrum Therapeutics, Inc. Director Nov 12, 2024

Insider Transactions Reported by Rachel King:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.